What Researchers Did
Researchers examined whether methylphenidate (Ritalin, used for ADHD) increases the risk of central nervous system oxygen toxicity seizures, using both human observational data from 75 diving cases and a mouse experiment with escalating methylphenidate doses.
What They Found
In human data, methylphenidate was not associated with increased seizure risk (OR 0.72, 95% CI 0.16 to 3.32). In mice, higher methylphenidate doses extended the time before seizure onset significantly (877 seconds at baseline versus 1,500 seconds at the highest dose, p=0.014), suggesting a possible protective effect.
What This Means for Canadian Patients
Canadians with ADHD who take methylphenidate and require HBOT should be reassured that available evidence does not show increased risk of oxygen seizures from this medication. Physicians should not withhold HBOT from patients on methylphenidate based on oxygen toxicity concerns alone.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The human sample was small (75 cases) from a specific military diving population; mice were exposed to very high oxygen pressures not typical of clinical HBOT.